(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione Basic information
- Product Name:
- (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione
- Synonyms:
-
- (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione
- TCS PIM-1 4a
- SMI-4a
- (Z)-5-(3-(trifluoroMethyl)benzylidene)thiazolidine-2,4-dione
- 2,4-Thiazolidinedione, 5-[[3-(trifluoromethyl)phenyl]methylene]-, (5Z)-
- TCS PIM-1 4a, >=98%
- (5E)-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,3-thiazolidine-2,4-dione
- (Z)-SMI-4a
- CAS:
- 438190-29-5
- MF:
- C11H6F3NO2S
- MW:
- 273.23
- EINECS:
- 200-256-5
- Product Categories:
-
- Inhibitors
- JAK
- STAT
- Inhibitor
- Mol File:
- 438190-29-5.mol
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione Chemical Properties
- Density
- 1.530±0.06 g/cm3(Predicted)
- storage temp.
- Desiccate at +4°C
- solubility
- DMSO: >10mg/mL
- form
- powder
- pka
- 7.38±0.20(Predicted)
- color
- white to beige
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months.
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione Usage And Synthesis
Description
SMI-4a (438190-29-5) is a selective, ATP-competitive inhibitor of the Pim protein kinases (IC50 = 24 and 100 nM for Pim-1 and Pim-2 respectively). Selective over a panel of ~50 other kinases.1?Induces cell cycle arrest in leukemia and prostate cancer cells.2?Blocks the growth of a wide range of myeloid and lymphoid cell lines with precursor T-cell lymphoblastic leukemia/lymphoma (pre-T-LBL/T-ALL) being highly sensitive.3?SMI-4a is a useful tool for exploring the involvement of Pim in cellular signaling.4?Cell permeable.
Uses
SMI-4a is an aldose reductase inhibitor as well as a COX-2 inhibitor, a potential agent in the inhibition and treatment of cancer and cancer cell lines.
IC 50
PIM1: 24 μM (IC50); PIM1: 0.6 μM (Ki); PIM2: 100 μM (IC50)
References
[1] ZUPING XIA. Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases[J]. Journal of Medicinal Chemistry, 2008, 52 1: 74-86. DOI:10.1021/jm800937p
[2] ZANNA BEHARRY. Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells.[J]. Molecular Cancer Therapeutics, 2009, 8 6: 1473-1483. DOI:10.1158/1535-7163.mct-08-1037
[3] YING-WEI LIN. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.[J]. Blood, 2010, 115 4: 824-833. DOI:10.1182/blood-2009-07-233445
[4] FENGXUE ZHANG. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.[J]. Cancer Biology & Therapy, 2009, 8 9: 846-853. DOI:10.4161/cbt.8.9.8210
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedioneSupplier
- Tel
- sales@boylechem.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 17702719238 18971495150;
- sales@sun-shinechem.com
- Tel
- 0531-88811783
- sales@trio-pharmatech.com